MedPath

MAALOX PLUS SUSPENSION EXTRA STRENGTH

MAALOX PLUS SUSPENSION EXTRA STRENGTH

Discontinued
DIN Number

02162342

Drug Class

Human

Market Date

Jul 30, 1996

Company
HC

novartis consumer health canada inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02162342
AIG Number0331160002
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
A02AF02 ORDINARY SALT COMBINATIONS AND ANTIFLATULENTS
Product Specifications
Dosage FormSuspension
Route of AdministrationOral
AHFS Classification56:04.00
Health Canada Classification

ACTIVE INGREDIENTS (3)

ALUMINUM HYDROXIDEActive
Strength: 100 MG / ML
Monograph: ALUMINUM HYDROXIDE
MAGNESIUM HYDROXIDEActive
Strength: 90 MG / ML
Monograph: MAGNESIUM HYDROXIDE
SIMETHICONEActive
Strength: 8 MG / ML
Monograph: SIMETHICONE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.